Characteristic | DUOPAP | CPAP | P value |
---|---|---|---|
Male, n (%) | 40(54.1%) | 32(43.2) | 0.188 |
Female, n (%) | 34(45.9%) | 42(56.8) | |
Cesarean delivery, n (%) | 52(70.3%) | 57(77%) | 0.351 |
Vaginal delivery, n (%) | 22(29.7%) | 17(23%) | |
Gestational age, weeks (mean ± SD) | 31.32±1.53 | 31.13±1.77 | 0.618 |
Median (IQR) | 31.55(2.1) | 31.35(2.8) | |
Body weight, gr (mean ±SD) | 1415±233.15 | 1377.91±260.24 | 0.357 |
Antenatal steroids, n (%) First does | 70(94.6%) | 68(91.9%) | 0.798 |
Antenatal steroids, n (%) second dose | 2(2.7%) | 3(4.1%) | |
Without Antenatal steroids, n (%) | 2(2.7%) | 3(4.1%) | |
APGAR 1 min (mean+ SD) | 6.15±1.08 | 6.08±0.89 | 0.819 |
Median (IQR) | 6(2) | 6(2) | |
APGAR 5 min (mean± SD) | 7.69 ±0.79 | 7.70±0/81 | 0.928 |
Median (IQR) | 8(1) | 8(1) | |
PPROM, n (%) | 12(17.6%) | 7(9.6%) | 0.161 |
Age Mother, yrs. (mean ± SD) Mean IQR | 30.08±7.44 | 29.24±6.59 | 0.470 |
Gestational age group, n (%) | |||
 28-30 weeks | 12 (16%) | 19 (26%) | 0.879 |
 30-32 weeks | 34 (46%) | 23 (31%) |  |
 32-34 weeks | 28 (38%) | 32 (43%) |  |